rs61746763

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001126108.2(SLC12A3):​c.1865A>G​(p.Asn622Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00322 in 1,555,576 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 34 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 46 hom. )

Consequence

SLC12A3
NM_001126108.2 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 9.21

Publications

8 publications found
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SLC12A3 Gene-Disease associations (from GenCC):
  • Gitelman syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_001126108.2
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 138 curated pathogenic missense variants (we use a threshold of 10). The gene has 18 curated benign missense variants. Gene score misZ: -0.93606 (below the threshold of 3.09). Trascript score misZ: 0.71313 (below the threshold of 3.09). GenCC associations: The gene is linked to Gitelman syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.005542457).
BP6
Variant 16-56885304-A-G is Benign according to our data. Variant chr16-56885304-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0134 (2038/152096) while in subpopulation AFR AF = 0.0444 (1843/41532). AF 95% confidence interval is 0.0427. There are 34 homozygotes in GnomAd4. There are 971 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A3NM_001126108.2 linkc.1865A>G p.Asn622Ser missense_variant Exon 15 of 26 ENST00000563236.6 NP_001119580.2 P55017-1
SLC12A3NM_000339.3 linkc.1865A>G p.Asn622Ser missense_variant Exon 15 of 26 NP_000330.3 P55017-2
SLC12A3NM_001126107.2 linkc.1862A>G p.Asn621Ser missense_variant Exon 15 of 26 NP_001119579.2 P55017-3
SLC12A3NM_001410896.1 linkc.1862A>G p.Asn621Ser missense_variant Exon 15 of 26 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkc.1865A>G p.Asn622Ser missense_variant Exon 15 of 26 1 NM_001126108.2 ENSP00000456149.2 P55017-1
SLC12A3ENST00000438926.6 linkc.1865A>G p.Asn622Ser missense_variant Exon 15 of 26 1 ENSP00000402152.2 P55017-2
SLC12A3ENST00000566786.5 linkc.1862A>G p.Asn621Ser missense_variant Exon 15 of 26 1 ENSP00000457552.1 P55017-3
SLC12A3ENST00000262502.5 linkc.1862A>G p.Asn621Ser missense_variant Exon 15 of 26 5 ENSP00000262502.5 J3QSS1

Frequencies

GnomAD3 genomes
AF:
0.0134
AC:
2031
AN:
151978
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0443
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00335
Gnomad ASJ
AF:
0.0312
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000626
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000324
Gnomad OTH
AF:
0.00575
GnomAD2 exomes
AF:
0.00477
AC:
777
AN:
162868
AF XY:
0.00363
show subpopulations
Gnomad AFR exome
AF:
0.0436
Gnomad AMR exome
AF:
0.00209
Gnomad ASJ exome
AF:
0.0306
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000620
Gnomad OTH exome
AF:
0.00221
GnomAD4 exome
AF:
0.00211
AC:
2967
AN:
1403480
Hom.:
46
Cov.:
30
AF XY:
0.00198
AC XY:
1374
AN XY:
692678
show subpopulations
African (AFR)
AF:
0.0473
AC:
1506
AN:
31840
American (AMR)
AF:
0.00207
AC:
75
AN:
36266
Ashkenazi Jewish (ASJ)
AF:
0.0309
AC:
778
AN:
25194
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36200
South Asian (SAS)
AF:
0.000202
AC:
16
AN:
79396
European-Finnish (FIN)
AF:
0.0000202
AC:
1
AN:
49468
Middle Eastern (MID)
AF:
0.00719
AC:
41
AN:
5706
European-Non Finnish (NFE)
AF:
0.000215
AC:
232
AN:
1081234
Other (OTH)
AF:
0.00547
AC:
318
AN:
58176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
168
335
503
670
838
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0134
AC:
2038
AN:
152096
Hom.:
34
Cov.:
32
AF XY:
0.0131
AC XY:
971
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.0444
AC:
1843
AN:
41532
American (AMR)
AF:
0.00334
AC:
51
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0312
AC:
108
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4788
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000324
AC:
22
AN:
67982
Other (OTH)
AF:
0.00569
AC:
12
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
102
203
305
406
508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00609
Hom.:
32
Bravo
AF:
0.0153
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0359
AC:
155
ESP6500EA
AF:
0.00178
AC:
15
ExAC
AF:
0.00284
AC:
314
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Benign:3
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.71
.;.;D;T
Eigen
Benign
0.12
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.79
T;T;T;T
MetaRNN
Benign
0.0055
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
.;L;L;.
PhyloP100
9.2
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-2.0
N;N;N;N
REVEL
Benign
0.098
Sift
Benign
0.66
T;T;T;T
Sift4G
Benign
0.66
T;T;T;T
Polyphen
0.048
B;B;P;.
Vest4
0.83
MVP
0.95
MPC
0.21
ClinPred
0.027
T
GERP RS
5.4
Varity_R
0.19
gMVP
0.80
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61746763; hg19: chr16-56919216; API